Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001438588-13-000009
Filing Date
2013-02-13
Accepted
2013-02-13 18:51:25
Documents
1
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 5  
1 PRIMARY DOCUMENT edgardoc.xml 5 5395
  Complete submission text file 0001438588-13-000009.txt   6891
Mailing Address 2910 SEVENTH ST BERKLEY CA 94710
Business Address 2910 SEVENTH ST BERKELEY CA 94710 5106441170
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 942756657 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XOMA, LTD. 2910 SEVENTH STREET BERKELEY CA 94710
Business Address
SCANNON PATRICK J MD PHD (Reporting) CIK: 0001222790 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-14710 | Film No.: 13605237